(Q35894032)

11 August 2017

1 reference

title

Respiratory infections and asthma: current treatment strategies (English)

1 reference

11 August 2017

1 reference

Miles Weinberger

1

1 reference

11 August 2017

publication date

1 October 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

9

1 reference

11 August 2017

issue

19

1 reference

11 August 2017

page(s)

831-837

1 reference

Viruses and asthma: Inception, exacerbation, and possible prevention

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Increased incidence of bronchial reactivity in children with a history of bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Clinical patterns and natural history of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Respiratory viruses and exacerbations of asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Respiratory infections and the autumn increase in asthma morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Trends in childhood asthma: prevalence, health care utilization, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Hospitalization trends for paediatric asthma in eastern Finland: a 10-yr survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Metapneumovirus and acute wheezing in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Children with respiratory disease associated with metapneumovirus in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

A link between chronic asthma and chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Management of acute asthma attacks associated with respiratory tract infection: a postal survey of general practitioners in the U.K.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Misuse of antimicrobials in children with asthma and bronchiolitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Routine antibiotics in hospital management of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Antibiotics in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Effect of a single oral dose of prednisolone in acute childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Efficacy of oral dexamethasone in outpatients with acute bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Corticosteroids for first-time young wheezers: current status of the controversy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Corticosteroids for exacerbations of asthma: problems and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Treatment strategies for viral respiratory infection-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Limitations of maintenance therapy for viral respiratory infection-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

The effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Immunopathogenesis of vaccine-enhanced RSV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

The future of respiratory syncytial virus vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Early ribavarin treatment of bronchiolitis: effect on long-term respiratory morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

New drugs and treatment for respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

The major human rhinovirus receptor is ICAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Modification of experimental rhinovirus colds by receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Prevention of Human Rhinovirus Infection by Multivalent Fab Molecules Directed against ICAM-1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903239-8

7 January 2021

10.1016/S1359-6446(04)03239-8

Identifiers

DOI

1 reference

11 August 2017

1 reference